Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Drengo
    Junior Member
    • Sep 2019
    • 1

    #1

    Re-mapping contigs or predicted genes?

    Hi!
    I'm quite new to bioinformatics and am currently running into a dilemma on how to approach my re-mapping.
    I have successfully assembled my FASTQ-files (reads) and now have my contigs in FASTA files.
    From these FASTA-files, I want to predict its genes (with Prodigal) and find the depth (abundance) of the predicted genes. However, I am unsure if I should re-map my contigs back to my reads first, or if I should gene predict first, and then re-map the predicted genes back to the reads. As I see it, by re-mapping the predicted genes, I risk losing some of the reads not entirely in the gene. However, by re-mapping the contigs, I get a depth for all the reads on the contig, but will then have to correlate that data to the predicted genes somehow. Do you have any suggestions or preferences? And if you do, why would you choose one over the other.

    Thank you very much in advance!
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Cross-posted on biostars: https://www.biostars.org/p/398986/

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:35 AM
    0 responses
    7 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...